Literature DB >> 9006329

Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.

M M Tompkins1, E J Basgall, E Zamrini, W D Hill.   

Abstract

In Parkinson's disease and other Lewy-body-associated disorders, the substantia nigra pars compacta undergoes degeneration, but the mechanism of cell death has not been previously described. The substantia nigra of normal and Alzheimer's disease cases were compared with substantia nigra from patients with Lewy-body-associated disorders (Parkinson's disease, concomitant Alzheimer's/Parkinson's disease, and diffuse Lewy body disease) using in situ end labeling to detect fragmented DNA. In situ end-labeled neurons demonstrated changes resembling apoptosis: nuclear condensation, chromatin fragmentation, and formation of apoptotic-like bodies. Ultrastructural analysis confirmed nuclear condensation and formation of apoptotic-like bodies. Apoptotic-like changes were seen in the substantia nigra of both normal and diseased cases; concomitant Alzheimer's/Parkinson's disease and diffuse Lewy body disease cases had significantly higher amounts of apoptotic-like changes than normal controls or Alzheimer patients. The finding of neuronal death by apoptosis may have relevance for the development of new treatment strategies for Parkinson's disease and related disorders.

Entities:  

Mesh:

Year:  1997        PMID: 9006329      PMCID: PMC1858540     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  67 in total

1.  Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia).

Authors:  W R Gibb; M M Esiri; A J Lees
Journal:  Brain       Date:  1987-10       Impact factor: 13.501

2.  Parkinson's disease.

Authors:  N P Quinn; F A Husain
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

3.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

4.  Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease.

Authors:  I Ziv; E Melamed; N Nardi; D Luria; A Achiron; D Offen; A Barzilai
Journal:  Neurosci Lett       Date:  1994-03-28       Impact factor: 3.046

5.  Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance.

Authors:  J Searle; J F Kerr; C J Bishop
Journal:  Pathol Annu       Date:  1982

6.  Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia.

Authors:  G Pilar; L Landmesser
Journal:  J Cell Biol       Date:  1976-02       Impact factor: 10.539

Review 7.  A radical hypothesis for neurodegeneration.

Authors:  C W Olanow
Journal:  Trends Neurosci       Date:  1993-11       Impact factor: 13.837

8.  Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

Authors:  F Boller; T Mizutani; U Roessmann; P Gambetti
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422

9.  Mitochondrial respiratory chain inhibitors induce apoptosis.

Authors:  E J Wolvetang; K L Johnson; K Krauer; S J Ralph; A W Linnane
Journal:  FEBS Lett       Date:  1994-02-14       Impact factor: 4.124

10.  Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Clin Neuropathol       Date:  1984 Sep-Oct       Impact factor: 1.368

View more
  43 in total

1.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

Authors:  A Hartmann; S Hunot; P P Michel; M P Muriel; S Vyas; B A Faucheux; A Mouatt-Prigent; H Turmel; A Srinivasan; M Ruberg; G I Evan; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  Role of glial cells in neurotoxin-induced animal models of Parkinson's disease.

Authors:  Hironori Yokoyama; Hiroto Uchida; Hayato Kuroiwa; Jiro Kasahara; Tsutomu Araki
Journal:  Neurol Sci       Date:  2010-11-24       Impact factor: 3.307

3.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.

Authors:  K A Conway; S J Lee; J C Rochet; T T Ding; R E Williamson; P T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

4.  α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.

Authors:  Zane S Martin; Volker Neugebauer; Kelly T Dineley; Rakez Kayed; Wenru Zhang; Lindsay C Reese; Giulio Taglialatela
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

5.  Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

6.  Evidence for neurogenesis in the adult mammalian substantia nigra.

Authors:  Ming Zhao; Stefan Momma; Kioumars Delfani; Marie Carlen; Robert M Cassidy; Clas B Johansson; Hjalmar Brismar; Oleg Shupliakov; Jonas Frisen; Ann Marie Janson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-05       Impact factor: 11.205

Review 7.  The role of apoptosis in neurodegenerative diseases.

Authors:  P Desjardins; S Ledoux
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

8.  Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.

Authors:  Furong Xu; Hui Wang; Ju Tian; Haiyan Xu
Journal:  Neurochem Res       Date:  2021-05-29       Impact factor: 3.996

9.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

Review 10.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.